Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Smalley

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Medical Clinics of North America|May 1, 1986
Interferon in the treatment of cancerR V Smalley
Drugs Under Experimental and Clinical Research|January 1, 1986
Phase I trials of biological response modifiersR V Smalley, R K Oldham
Critical Reviews in Oncology/Hematology|January 1, 1984
Biological response modifiers: preclinical evaluation and clinical activityR V Smalley, R K Oldham
Oncology (Williston Park, N.Y.)|September 28, 1999
Role of interferon-alfa in NHL: still controversial?S Haase-Statz, R V Smalley
Seminars in Oncology|December 1, 1990
Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research programR V Smalley, R B Sigal, S Anderson
American Journal of Clinical Oncology|April 1, 1982
Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastasesR V Smalley, D M Scogna, L S Malmud
World Journal of Surgery|September 1, 1989
Hyperthermic perfusion with chemotherapy for melanoma of the extremitiesF Ghussen, I Krüger, R V Smalley, et al.
Blood|July 1, 1977
Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapyR V Smalley, J Vogel, C M Huguley, et al.
The Journal of Urology|February 1, 1981
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinomaR V Smalley, A A Bartolucci, G Hemstreet, et al.
Cancer|February 1, 1981
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristineC A Presant, S Lowenbraun, A A Bartolucci, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Medical Clinics of North America|May 1, 1986
Interferon in the treatment of cancerR V Smalley
Drugs Under Experimental and Clinical Research|January 1, 1986
Phase I trials of biological response modifiersR V Smalley, R K Oldham
Critical Reviews in Oncology/Hematology|January 1, 1984
Biological response modifiers: preclinical evaluation and clinical activityR V Smalley, R K Oldham
Oncology (Williston Park, N.Y.)|September 28, 1999
Role of interferon-alfa in NHL: still controversial?S Haase-Statz, R V Smalley
Seminars in Oncology|December 1, 1990
Front-line hormonal therapy for patients with advanced breast cancer: a community oncology research programR V Smalley, R B Sigal, S Anderson
American Journal of Clinical Oncology|April 1, 1982
Advanced breast cancer with bone-only metastases: a chemotherapeutically responsive pattern of metastasesR V Smalley, D M Scogna, L S Malmud
World Journal of Surgery|September 1, 1989
Hyperthermic perfusion with chemotherapy for melanoma of the extremitiesF Ghussen, I Krüger, R V Smalley, et al.
Blood|July 1, 1977
Chronic granulocytic leukemia: cytogenetic conversion of the bone marrow with cycle-specific chemotherapyR V Smalley, J Vogel, C M Huguley, et al.
The Journal of Urology|February 1, 1981
A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinomaR V Smalley, A A Bartolucci, G Hemstreet, et al.
Cancer|February 1, 1981
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristineC A Presant, S Lowenbraun, A A Bartolucci, et al.
Pageof 4